Format

Send to

Choose Destination
Dermatol Surg. 1996 Mar;22(3):255-61.

Basal cell carcinoma. Identification and treatment of the high-risk patient.

Author information

1
Department of Dermatology, Mayo Clinic Jacksonville, FL 32224, USA.

Abstract

BACKGROUND:

Some cutaneous basal cell carcinomas have a significant potential to recur, disfigure, and metastasize.

OBJECTIVES AND METHODS:

The identification and selection of treatment of these high risk carcinomas is based on a review of studies of recurrence, giant size, metastasis, and mortality.

RESULTS:

Basal cell carcinomas with any of the following: long duration, location in the mid face or ear, larger than 2 cm, with aggressive histologic subtype, previous treatment, neglected, or a history of radiation exposure, should be considered "high risk."

CONCLUSION:

For basal cell carcinomas with this high risk profile, complete excision by margin control or total destruction should be considered.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center